|
70
|
242
|
4qzzD |
Ycp in complex with omuralide |
|
57
|
204
|
4qvnI |
Ycp beta5-m45v mutant in complex with bortezomib |
|
68
|
233
|
4quxM |
Ycp beta5-a49t-mutant |
|
59
|
222
|
4qz0L |
Ycp beta5-m45v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
60
|
196
|
4qz4N |
Ycp beta5-a49s mutant in complex with the epoxyketone inhibitor onx 0914 |
|
70
|
242
|
4qvvD |
Ycp beta5-a49v mutant in complex with bortezomib |
|
69
|
243
|
4qv3F |
Ycp beta5-m45v mutant |
|
71
|
243
|
4qwxF |
Ycp in complex with the epoxyketone inhibitor onx 0914 |
|
71
|
243
|
4qw4F |
Ycp in complex with carfilzomib |
|
61
|
196
|
4qwrN |
Ycp beta5-c52f mutant in complex with carfilzomib |
|
59
|
222
|
4qwlL |
Ycp beta5-a50v mutant in complex with carfilzomib |
|
64
|
231
|
4r17E |
Ligand-induced aziridine-formation at subunit beta5 of the yeast 20s proteasome |
|
67
|
244
|
4qvqB |
Ycp beta5-m45i mutant in complex with bortezomib |
|
60
|
196
|
4qv0N |
Ycp beta5-a49t-a50v-double mutant |
|
66
|
213
|
4r671 |
Human constitutive 20s proteasome in complex with carfilzomib |
|
68
|
250
|
4qz7A |
Ycp beta5-a50v mutant in complex with the epoxyketone inhibitor onx 0914 |
|
67
|
242
|
4qwuD |
Ycp beta5-c52f mutant in complex with bortezomib |
|
59
|
196
|
4qvvN |
Ycp beta5-a49v mutant in complex with bortezomib |
|
59
|
222
|
4qw4L |
Ycp in complex with carfilzomib |
|
67
|
212
|
4qv6K |
Ycp beta5-a49v mutant |
|
61
|
195
|
4qluJ |
Ycp in complex with tripeptidic epoxyketone inhibitor 9 |
|
70
|
243
|
4r00F |
Ycp beta5-c52f mutant in complex with omuralide |
|
65
|
233
|
4qwxM |
Ycp in complex with the epoxyketone inhibitor onx 0914 |
|
62
|
195
|
4qwgJ |
Ycp beta5-a49v mutant in complex with carfilzomib |
|
66
|
233
|
4r00M |
Ycp beta5-c52f mutant in complex with omuralide |
|
71
|
243
|
4qxjF |
Ycp beta5-m45a mutant in complex with the epoxyketone inhibitor onx 0914 |
|
64
|
231
|
4qvyE |
Ycp beta5-a49t-mutant in complex with bortezomib |
|
63
|
241
|
4quyG |
Ycp beta5-a49s-mutant |
|
61
|
231
|
4qz4E |
Ycp beta5-a49s mutant in complex with the epoxyketone inhibitor onx 0914 |
|
66
|
242
|
4qvqD |
Ycp beta5-m45i mutant in complex with bortezomib |
|
59
|
226
|
4qv7H |
Ycp beta5-a50v mutant |
|
64
|
213
|
4r3o1 |
Human constitutive 20s proteasome |
|
63
|
231
|
4qw4E |
Ycp in complex with carfilzomib |
|
71
|
243
|
4qv9F |
Ycp beta5-c63f mutant |
|
72
|
212
|
4qzxK |
Ycp beta5-c63f mutant in complex with the epoxyketone inhibitor onx 0914 |
|
61
|
196
|
4qwsN |
Ycp beta5-c63f mutant in complex with carfilzomib |
|
62
|
195
|
4qwxJ |
Ycp in complex with the epoxyketone inhibitor onx 0914 |
|
61
|
196
|
4qw7N |
Ycp beta5-m45t mutant in complex with carfilzomib |
|
61
|
222
|
4qv9L |
Ycp beta5-c63f mutant |
|
72
|
212
|
4qz2K |
Ycp beta5-m45i mutant in complex with the epoxyketone inhibitor onx 0914 |
|
59
|
226
|
4qvqH |
Ycp beta5-m45i mutant in complex with bortezomib |
|
71
|
244
|
4qv0B |
Ycp beta5-a49t-a50v-double mutant |
|
63
|
241
|
4qz5G |
Ycp beta5-a49t-mutant in complex with onx 0914 |
|
64
|
233
|
4qwsM |
Ycp beta5-c63f mutant in complex with carfilzomib |
|
63
|
241
|
4qv8G |
Ycp beta5-c52f mutant |
|
70
|
240
|
4qzzC |
Ycp in complex with omuralide |
|
63
|
241
|
4qwlG |
Ycp beta5-a50v mutant in complex with carfilzomib |
|
59
|
226
|
4qzzH |
Ycp in complex with omuralide |
|
56
|
204
|
4qxjI |
Ycp beta5-m45a mutant in complex with the epoxyketone inhibitor onx 0914 |
|
68
|
250
|
4qv8A |
Ycp beta5-c52f mutant |
